Virtus ETF Advisers LLC Pro Qr Therapeutics N.V. Transaction History

Virtus ETF Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$5.84 - $10.51 $133,957 - $241,078	-22,938 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$5.76 - $9.44 $7,361 - $12,064	-1,278 Reduced 5.28%	22,938 $132,000
Q2 2019 Aug 13, 2019	BUY	$9.1 - $15.55 $84,548 - $144,475	9,291 Added 62.25%	24,216 $220,000
Q1 2019 May 14, 2019	SELL	$12.5 - $18.48 $21,962 - $32,469	-1,757 Reduced 10.53%	14,925 $207,000
Q4 2018 Feb 05, 2019	BUY	$15.25 - $22.4 $254,400 - $373,676	16,682 New	16,682 $263,000

17.6M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $161M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.